Strategic Investment Recent equity investment of 25M from Edwards and a concurrent 25M connection with JC Medical acquisition signals strong financial backing and potential funding for scale. Leverage this momentum to position Genesis Medtech for larger procurement cycles and strategic partnerships with hospital networks and distributors.

AI in Surgery Genesis is actively developing AI projects in surgery in collaboration with NUHS clinicians. This creates opportunities to pitch AI-enabled decision support, workflow optimization, and data analytics solutions to academic medical centers and integrated delivery networks.

Robotics Expansion Launch of OMNIBOT robotic-assisted surgical system expands the product portfolio into advanced minimally invasive solutions. Target surgical departments and hospitals investing in robotics, offering training, service contracts, and integration with existing operating room ecosystems.

Domestic Collaboration Partnership with National University Health System signals a beachehead for clinical validation and iterative product development. Use this to propose co-development programs, clinical trials, and early access programs to drive adoption in regional markets.

Global Manufacturing Integrated capabilities from R&D to manufacturing and global distribution indicate readiness for scaled supply to hospitals and regional distributors. Position as a turnkey supplier for high-quality devices across surgical, cardiology, and vascular interventional specialties with scalable support and training.